2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow ARQ 197: new trials by email Literature Review of ARQ 197 trials Research Report on ARQ 197
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) ARQ197, Placebo - Liver Cancer | Phase 3 | Completed | Kyowa Kirin Co., Ltd. | 386 | 2014-01-01 | 2017-10-09 |
| Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy Tivantinib, Placebo - Hepatocellular Carcinoma | Phase 3 | Completed | Daiichi Sankyo | 383 | 2012-12-27 | 2021-04-06 |
Carcinoma (1) · Carcinoma, Hepatocellular (1) · Liver Neoplasms (1)
Daiichi Sankyo (1) · Kyowa Kirin Co., Ltd. (1)
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Netherlands (1) · New Zealand (1) · Portugal (1) · Spain (1) · Sweden (1)